SEC Form 4 · accession 0001209191-15-025565
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Himawan
Director
Period of report
Mar 9, 2015
Accepted (ET)
Mar 12, 2015 · 1:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 9, 2015 | S | 329,912 | $21.91 | D | 1,284,915 | I | See footnote |
| Ordinary SharesF1 | Mar 10, 2015 | S | 1,284,915 | $21.84 | D | 0 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held directly by Essex Woodlands Health Ventures Fund, VII, L.P. (the "Fund"). The Reporting Person is a manager of Essex Woodlands Health Ventures VII, L.L.C., which is the general partner of Essex Woodlands Health Ventures VII, L.P., the general partner of the Fund. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.